Piramal Group

Piramal Group is an Indian multinational conglomerate headquartered in Mumbai, with operations in financial services, pharmaceuticals, and real estate. Ajay Piramal established the group in 1984 through the acquisition of Gujarat Glass Limited; the family had previously been in textiles. In 1988 the group entered healthcare through the purchase of Nicholas Laboratories' Indian operations. In September 2025, the parent company Piramal Enterprises Limited (PEL) completed a reverse merger into its subsidiary Piramal Finance Limited (formerly Piramal Capital & Housing Finance), which now functions as the group's primary listed financial services arm. The pharmaceutical division was listed separately as Piramal Pharma Limited in 2022. As of 2026, the group operates in over 30 countries. Ajay Piramal chairs the group; Anand Piramal chairs Piramal Finance following the 2025 merger.